CDLX
Cardlytics, Inc.
Next earnings Aug 4, 2026 · consensus $-1.09 EPS, $37.6M rev
Last earnings -1.6% on 2026-05-07
$4.71
▼ -5.23%$4.71▼ -71.63%
over 1Y
L $4.71EODHDH $31.20
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-5.2%
1W-9.8%
1M-34.0%
3M-49.5%
YTD-57.9%
1Y-71.6%
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 10 analysts
Sell
High return on equity (1590.2%); but revenue fell -16.9% YoY.
Revenue (FY2025) $212M · FY2025
Cardlytics, Inc. shows $212M in FY2025 revenue (-16.9% YoY), a -48.7% net margin, and 1590.2% ROE.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $259M | $277M | $285M | $256M | $212M |
| Gross profit | — | — | — | — | — |
| Operating income | -$123M | -$458M | -$136M | -$195M | -$102M |
| Net income | -$129M | -$465M | -$135M | -$189M | -$103M |
| Diluted EPS | — | -$13.92 | -$3.69 | -$3.91 | -$1.95 |
| Net margin | -49.7% | -167.9% | -47.2% | -74.1% | -48.7% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$423M
EV / EBITDA—
EV / Sales2.0
EV / FCF48.0
P / FCF29.4
PEG (trailing)—
Earnings yield-39.9%
FCF yield3.4%
Quality & risk
ROIC (est.)—
Free cash flow$8.81M
Total debt$213M
Net cash-$164M
Altman Z-Score-6.53 distress
Piotroski F-Score5/8
Capital returns
Buyback yield0.0%
Dividend yield (est.)—
Shareholder yield0.0%
Shares Δ YoY+5.7%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsRed flag in recent filings — delisting notice (2026-06-03). Worth a closer look.
Recent filings
all on EDGAR ↗8-KPeriod ending 2026-06-032026-06-03open ↗4Period ending 2026-05-202026-05-21open ↗4Period ending 2026-05-202026-05-21open ↗4Period ending 2026-05-202026-05-21open ↗4Period ending 2026-05-202026-05-21open ↗4Period ending 2026-05-202026-05-21open ↗4Period ending 2026-05-202026-05-21open ↗8-KPeriod ending 2026-05-202026-05-20open ↗4Period ending 2026-05-152026-05-19open ↗8-KPeriod ending 2026-05-102026-05-12open ↗10-QPeriod ending 2026-03-312026-05-07open ↗8-KPeriod ending 2026-05-072026-05-07open ↗
Frequently asked
- Is Cardlytics, Inc. (CDLX) a buy?
- CDLX currently carries a Avoid rating with 3/5 conviction, derived from its latest SEC filings. High return on equity (1590.2%); but revenue fell -16.9% YoY.
- What is Cardlytics, Inc.'s quality score?
- CDLX scores 42.588235294117645/100 (grade D) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001666071, latest 10-Q filed 2026-05-07) · EODHD · as of 6/24/2026, 1:19:39 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.